Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Rethinking alcohol interventions in health care: a thematic meeting of the International Network on Brief Interventions for Alcohol & Other Drugs (INEBRIA).

Glass JE, Andréasson S, Bradley KA, Finn SW, Williams EC, Bakshi AS, Gual A, Heather N, Sainz MT, Benegal V, Saitz R.

Addict Sci Clin Pract. 2017 May 10;12(1):14. doi: 10.1186/s13722-017-0079-8.

3.

Finding the loopholes: a cross-sectional qualitative study of systemic barriers to treatment access for women drug court participants.

Morse DS, Silverstein J, Thomas K, Bedel P, Cerulli C.

Health Justice. 2015 Dec;3:12. Epub 2015 Jun 17.

4.

Sex-Related Disparities in Criminal Justice and HIV Treatment Outcomes: A Retrospective Cohort Study of HIV-Infected Inmates.

Meyer JP, Cepeda J, Taxman FS, Altice FL.

Am J Public Health. 2015 Sep;105(9):1901-10. doi: 10.2105/AJPH.2015.302687. Epub 2015 Jul 16.

5.

Specialty substance use disorder services following brief alcohol intervention: a meta-analysis of randomized controlled trials.

Glass JE, Hamilton AM, Powell BJ, Perron BE, Brown RT, Ilgen MA.

Addiction. 2015 Sep;110(9):1404-15. doi: 10.1111/add.12950. Epub 2015 Jun 3.

6.

Potential radiating effects of misusing substances among medical patients receiving brief intervention.

Gryczynski J, Mitchell SG, Ondersma SJ, O'Grady KE, Schwartz RP.

J Subst Abuse Treat. 2015 Aug;55:39-44. doi: 10.1016/j.jsat.2015.02.003. Epub 2015 Feb 23.

7.

A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders.

Gastfriend DR.

Ann N Y Acad Sci. 2014 Oct;1327:112-30. doi: 10.1111/nyas.12538. Epub 2014 Sep 18. Review.

8.

Prescription opioid abuse: a literature review of the clinical and economic burden in the United States.

Meyer R, Patel AM, Rattana SK, Quock TP, Mody SH.

Popul Health Manag. 2014 Dec;17(6):372-87. doi: 10.1089/pop.2013.0098. Review.

9.

Co-occurring risk factors for arrest among persons with opioid abuse and dependence: implications for developing interventions to limit criminal justice involvement.

Fisher WH, Clark R, Baxter J, Barton B, O'Connell E, Aweh G.

J Subst Abuse Treat. 2014 Sep;47(3):197-201. doi: 10.1016/j.jsat.2014.05.002. Epub 2014 Jun 14.

10.

Interim versus standard methadone treatment: a benefit-cost analysis.

Schwartz RP, Alexandre PK, Kelly SM, O'Grady KE, Gryczynski J, Jaffe JH.

J Subst Abuse Treat. 2014 Mar;46(3):306-14. doi: 10.1016/j.jsat.2013.10.003. Epub 2013 Oct 14.

11.

Substance Use Among Adolescents in California: A Latent Class Analysis.

Gilreath TD, Astor RA, Estrada JN, Johnson RM, Benbenishty R, Unger JB.

Subst Use Misuse. 2013 Aug 23. [Epub ahead of print]

12.

Directed funding to address under-provision of treatment for substance use disorders: a quantitative study.

Frakt AB, Trafton J, Wallace A, Neuman M, Pizer S.

Implement Sci. 2013 Jul 18;8:79. doi: 10.1186/1748-5908-8-79.

13.

Offender diversion into substance use disorder treatment: the economic impact of California's proposition 36.

Anglin MD, Nosyk B, Jaffe A, Urada D, Evans E.

Am J Public Health. 2013 Jun;103(6):1096-102. doi: 10.2105/AJPH.2012.301168. Epub 2013 Apr 18.

14.

Characteristics of adults with substance use disorders expected to be eligible for Medicaid under the ACA.

Busch SH, Meara E, Huskamp HA, Barry CL.

Psychiatr Serv. 2013 Jun;64(6):520-6. doi: 10.1176/appi.ps.201200011.

15.

Economic analysis of a multi-site prevention program: assessment of program costs and characterizing site-level variability.

Corso PS, Ingels JB, Kogan SM, Foster EM, Chen YF, Brody GH.

Prev Sci. 2013 Oct;14(5):447-56. doi: 10.1007/s11121-012-0316-z.

16.

Blacks and Hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors.

Saloner B, Lê Cook B.

Health Aff (Millwood). 2013 Jan;32(1):135-45. doi: 10.1377/hlthaff.2011.0983.

17.

Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence.

Schwarz R, Zelenev A, Bruce RD, Altice FL.

J Subst Abuse Treat. 2012 Dec;43(4):451-7. doi: 10.1016/j.jsat.2012.03.008. Epub 2012 Apr 24.

18.

Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12-month outcomes.

Kidorf M, King VL, Gandotra N, Kolodner K, Brooner RK.

Drug Alcohol Depend. 2012 Jul 1;124(1-2):162-6. doi: 10.1016/j.drugalcdep.2011.12.008. Epub 2011 Dec 31.

19.

A treatment reengagement intervention for syringe exchangers.

Kidorf M, King VL, Peirce J, Kolodner K, Brooner RK.

J Subst Abuse Treat. 2011 Dec;41(4):415-21. doi: 10.1016/j.jsat.2011.06.008. Epub 2011 Aug 9.

20.

Can food be addictive? Public health and policy implications.

Gearhardt AN, Grilo CM, DiLeone RJ, Brownell KD, Potenza MN.

Addiction. 2011 Jul;106(7):1208-12. doi: 10.1111/j.1360-0443.2010.03301.x. Epub 2011 Feb 14.

Supplemental Content

Support Center